Parkinson's Disease Trial, Recruiting NCT07710625 Sponsor: Acibadem University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07710625
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Parkinson's disease at a mild to moderate stage (Hoehn and Yahr stage 1–3)
  • People aged between 40 and 85 years
  • People who score 24 or above on a standard memory and thinking test called the Mini-Mental State Examination (MMSE)
  • People who have enough thinking and communication ability to take part in assessments
  • People who are currently attending the Movement Disorders Outpatient Clinic in the Neurology Department
  • People who are willing to take part and sign a written consent form

Who may not be able to join:

  • People who have a psychiatric condition, such as major depression or a psychotic disorder
  • People who have been diagnosed with advanced dementia
  • People who have a chronic illness that is not well controlled, such as diabetes or high blood pressure
  • People who have a serious heart or breathing condition
  • People who have an additional bone, joint, or nervous system condition that could affect how they perform during tests
  • People who have severe vision or hearing difficulties that could interfere with assessments
  • People who are unable to work cooperatively with a physiotherapist during assessments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Acibadem University
Registry
ClinicalTrials.gov
Start date
25 May 2026
Est. completion
25 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Temperature Sensitivity Scale Total Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov